{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:27:05Z","timestamp":1784075225756,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci Behav Physiol"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1023\/a:1022107516333","type":"journal-article","created":{"date-parts":[[2003,3,22]],"date-time":"2003-03-22T00:29:05Z","timestamp":1048292945000},"page":"273-278","source":"Crossref","is-referenced-by-count":6,"title":["The Ability of New Non-Competitive Glutamate Receptor Blockers to Weaken Motor Disorders in Animals"],"prefix":"10.1007","volume":"33","author":[{"given":"N. I.","family":"Rukoyatkina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. V.","family":"Gorbunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"Gmiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Ya.","family":"Lukomskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"462662_CR1","first-page":"1138","volume":"86","author":"L. G. Magazanik","year":"2000","unstructured":"L. G. Magazanik, K. V. Bol'shakov, S. L. Buldakova, V. E. Gmiro, N. A. Dorofeeva, N. Ya. Lukomskaya, N. N. Potep'eva, M. V. Samoilova, D. B. Tikhonov, I. M. Fedorova, and E. V. Frolova, \u201cStructural characteristics of ionotropic glutamate receptors, identified by channel blockade,\u201d Ros. Fiziol. Zh. im. I. M. Sechenova, 86, 1138\u20131151 (2000).","journal-title":"Ros. Fiziol. Zh. im. I. M. Sechenova"},{"issue":"6","key":"462662_CR2","first-page":"626","volume":"86","author":"N. I. Rukoyatkina","year":"2000","unstructured":"N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, \u201cThe ability of glutamate receptor antagonists to ameliorate experimental catalepsy in rats,\u201d Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 6, 626\u2013634 (2000).","journal-title":"Ros. Fiziol. Zh. im. I. M. Sechenova"},{"key":"462662_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(93)90244-C","volume":"242","author":"A. Bissago","year":"1993","unstructured":"A. Bissago, P. Krzascik, E. Jankowska, W. Palejko, W. Kostowski, and W. Danysz, \u201cEffect of glutamate receptor antagonists on NMDA-and AMPA-induced convulsant effects in mice and rats,\u201d Eur. J. Pharmacol., 242, 213\u2013220 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"462662_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01382-6","volume":"50","author":"W. Danysz","year":"1998","unstructured":"W. Danysz and C. G. Parsons, \u201cN-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications,\u201d Pharmacol. Rev., 50, 597\u2013664 (1998).","journal-title":"Pharmacol. Rev."},{"key":"462662_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02260897","volume":"2","author":"P. J. Elliott","year":"1990","unstructured":"P. J. Elliott, S. P. Close, D. M. Walsh, A. G. Hayes, and A. S. Marriott, \u201cNeuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists,\u201d J. Neural. Transm., (Section P-D), 2, 91\u2013100 (1990).","journal-title":"J. Neural. Transm., (Section P-D)"},{"issue":"1","key":"462662_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02256627","volume":"10","author":"M. Gossel","year":"1995","unstructured":"M. Gossel, W. J. Schmidt, W. Loscher, W. Zajaczkowski, and W. Danysz, \u201cEffect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats,\u201d J. Neural Transm., (Section P-D), 10, No. 1, 27\u201339 (1995).","journal-title":"J. Neural Transm., (Section P-D)"},{"issue":"Suppl.8","key":"462662_CR7","first-page":"S7","volume":"44","author":"J. T. Greenamyre","year":"1994","unstructured":"J. T. Greenamyre and R. H. P. Porter, \u201cAnatomy and physiology of glutamate in CNS,\u201d Neurology, 44, Suppl. 8, S7\u2013S13 (1994).","journal-title":"Neurology"},{"key":"462662_CR8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.410300513","volume":"30","author":"T. Klockgether","year":"1991","unstructured":"T. Klockgether, L. Turski, T. Honore, Z. Zhang, D. M. Gash, R. Kurlan, and J. T. Greenamyre, \u201cThe AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys,\u201d Ann. Neurol., 30, 717\u2013723 (1991).","journal-title":"Ann. Neurol."},{"key":"462662_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02259538","volume":"3","author":"P.-A. Loschmann","year":"1991","unstructured":"P.-A. Loschmann, K. W. Lange, M. Kunow, K.-J. Rettig, P. Jahnig, T. Honore, L. Turski, H. Wachtel, P. Jenner, and C. D. Marsden, \u201cSynergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-DOPA in models of Parkinson's disease,\u201d J. Neural Transm., (Section P-D), 3, 203\u2013213 (1991).","journal-title":"J. Neural Transm., (Section P-D)"},{"issue":"4","key":"462662_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1098-2396(199708)26:4<381::AID-SYN6>3.0.CO;2-2","volume":"26","author":"P.-A. Loschmann","year":"1997","unstructured":"P.-A. Loschmann, U. Wullner, M. T. Heneka, J. B. Schulz, M. Kunow, H. Wachtel, and T. Klockgether, \u201cDifferential interaction of competitive NMDA and AMPA antagonists with selective dopamine D1 and D2 agonists in rat model of Parkinson's disease,\u201d Synapse, 26, No. 4, 381\u2013391 (1997).","journal-title":"Synapse"},{"key":"462662_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0014-2999(93)90149-C","volume":"235","author":"M. R. Luquin","year":"1993","unstructured":"M. R. Luquin, J. A. Obeso, J. Laguna, J. Guillen, and J. M. Martinez-Lage, \u201cThe AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys,\u201d Eur. J. Pharmacol., 235, 297\u2013300 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"462662_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1469-7793.1997.655ba.x","volume":"505","author":"L. G. Magazanik","year":"1997","unstructured":"L. G. Magazanik, S. L. Buldakova, M. V. Samoilova, V. E. Gmiro, I. R. Mellor, and P. N. R. Usherwood, \u201cBlock of open channels of recombinant AMPA receptors and native AMPA\/kainate receptors by adamantane derivatives,\u201d J. Physiol. (London), 505, 655\u2013663 (1997).","journal-title":"J. Physiol. (London)"},{"issue":"4","key":"462662_CR13","first-page":"269","volume":"47","author":"J. May","year":"1995","unstructured":"J. May, Z. Rogoz, G. Skuda, and T. Jaros, \u201cSome behavioral effects of CNQX and NBQX, AMPA receptor antagonists,\u201d Pol. J. Pharmacol., 47, No. 4, 269\u2013277 (1995).","journal-title":"Pol. J. Pharmacol."},{"issue":"1","key":"462662_CR14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0306-4522(97)00277-7","volume":"82","author":"A. Mele","year":"1998","unstructured":"A. Mele, D. N. Thomas, and A. Pert, \u201cDifferent neural mechanisms underlie dizocilpine maleate-and dopamine agonist-induced locomotor activity,\u201d Neurosci., 82, No. 1, 43\u201358 (1998).","journal-title":"Neurosci."},{"key":"462662_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0022-3565(25)11246-9","volume":"260","author":"M. Morelli","year":"1992","unstructured":"M. Morelli, S. Fenu, A. Pinna, and G. Di Chiara, \u201cOpposite effects of NMDA receptor blockade on dopaminergic D1-and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression,\u201d J. Pharmacol. Exp. Ther., 260, 402\u2013408 (1992).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1-2","key":"462662_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02250917","volume":"8","author":"K. Ossowska","year":"1994","unstructured":"K. Ossowska, \u201cThe role of excitatory amino acids in experimental models of Parkinson's disease,\u201d J. Neural Transm. (section P-D), 8, No. 1-2, 39\u201371 (1994).","journal-title":"J. Neural Transm. (section P-D)"},{"issue":"9","key":"462662_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1358\/dnp.1998.11.9.863689","volume":"11","author":"C. G. Parsons","year":"1998","unstructured":"C. G. Parsons, W. Danysz, and G. Quack, \u201cGlutamate in CNS disorders as target for drug development: an update,\u201d Drugs News Prospects, 11, No. 9, 523\u2013569 (1998).","journal-title":"Drugs News Prospects"},{"key":"462662_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","volume":"38","author":"C. D. Parsons","year":"1999","unstructured":"C. D. Parsons, W. Danysz, and G. Quack, \u201cMemantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data,\u201d Neuropharmacol., 38, 735\u2013767 (1999).","journal-title":"Neuropharmacol."},{"issue":"18","key":"462662_CR19","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1097\/00001756-199512150-00034","volume":"6","author":"J. J. Schuller","year":"1995","unstructured":"J. J. Schuller and J. F. Marshall, \u201cIntrastriatal DNQX induces rotation and pallidal fos in the 6-OHDA model of Parkinson's disease,\u201d Neuroreport, 6, No. 18, 2594\u20132608 (1995).","journal-title":"Neuroreport"},{"issue":"2-3","key":"462662_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF02259656","volume":"9","author":"B. Stauch-Slusher","year":"1995","unstructured":"B. Stauch-Slusher, K. C. Rissolo, K. F. Anzilotti, Jr., and P. F. Jackson, \u201cCentrally administrated AMPA antagonists increase locomotion in parkinsonian rats,\u201d J. Neural Transm. (section P-D), 9, No. 2-3, 145\u2013149 (1995).","journal-title":"J. Neural Transm. (section P-D)"},{"key":"462662_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(79)90279-6","volume":"59","author":"R. D. Sturgeon","year":"1979","unstructured":"R. D. Sturgeon, R. G. Fessler, and H. Y. Meltzer, \u201cBehavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats,\u201d Eur. J. Pharmacol., 59, 169\u2013179 (1979).","journal-title":"Eur. J. Pharmacol."},{"key":"462662_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bjp.0703043","volume":"126","author":"D. B. Tikhonov","year":"2000","unstructured":"D. B. Tikhonov, M. V. Samoilova, S. L. Buldakova, V. E. Gmiro, and L. G. Magazanik, \u201cVoltage-dependent block of native AMPA receptor channels by dicationic compounds,\u201d Brit. J. Pharmacol., 126, 265\u2013274 (2000).","journal-title":"Brit. J. Pharmacol."},{"issue":"5","key":"462662_CR23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.50.5.1323","volume":"50","author":"L. Verhagen-Metman","year":"1998","unstructured":"L. Verhagen-Metman, P. Del-Dotto, P. van den Munckhof, J. Fang, M. M. Mouradien, and T. N. Chase, \u201cAmantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease,\u201d Neurology, 50, No. 5, 1323\u20131326 (1998).","journal-title":"Neurology"}],"container-title":["Neuroscience and Behavioral Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022107516333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1022107516333\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1022107516333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:32:54Z","timestamp":1748323974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1022107516333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["462662"],"URL":"https:\/\/doi.org\/10.1023\/a:1022107516333","relation":{},"ISSN":["0097-0549","1573-899X"],"issn-type":[{"value":"0097-0549","type":"print"},{"value":"1573-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}